Selected article for: "gene expression and tissue specificity"
Author: Easty, David J.; Farr, Christine J.; Hennessy, Bryan T.
Title: New Roles for Vitamin D Superagonists: From COVID to Cancer
  • Cord-id: 5ojxskn0
  • Document date: 2021_3_31
    • ID: 5ojxskn0
    Snippet: Vitamin D is a potent steroid hormone that induces widespread changes in gene expression and controls key biological pathways. Here we review pathophysiology of vitamin D with particular reference to COVID-19 and pancreatic cancer. Utility as a therapeutic agent is limited by hypercalcemic effects and attempts to circumvent this problem have used vitamin D superagonists, with increased efficacy and reduced calcemic effect. A further caveat is that vitamin D mediates multiple diverse effects. Som
    Document: Vitamin D is a potent steroid hormone that induces widespread changes in gene expression and controls key biological pathways. Here we review pathophysiology of vitamin D with particular reference to COVID-19 and pancreatic cancer. Utility as a therapeutic agent is limited by hypercalcemic effects and attempts to circumvent this problem have used vitamin D superagonists, with increased efficacy and reduced calcemic effect. A further caveat is that vitamin D mediates multiple diverse effects. Some of these (anti-fibrosis) are likely beneficial in patients with COVID-19 and pancreatic cancer, whereas others (reduced immunity), may be beneficial through attenuation of the cytokine storm in patients with advanced COVID-19, but detrimental in pancreatic cancer. Vitamin D superagonists represent an untapped resource for development of effective therapeutic agents. However, to be successful this approach will require agonists with high cell-tissue specificity.

    Search related documents:
    Co phrase search for related documents
    • ace activity and activation signaling: 1
    • ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • acquire immune response and adaptive immune response: 1
    • activation signaling and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activation signaling and acute myeloid leukemia: 1
    • activation signaling and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active metabolite and acute ards respiratory distress syndrome: 1, 2, 3
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11